Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of GoodwillAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Harvard Bioscience (HBIO) Change in Receivables (2016 - 2025)

Historic Change in Receivables for Harvard Bioscience (HBIO) over the last 17 years, with Q3 2025 value amounting to $210000.0.

  • Harvard Bioscience's Change in Receivables rose 3548.39% to $210000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$693000.0, marking a year-over-year increase of 7066.05%. This contributed to the annual value of -$974000.0 for FY2024, which is 2024.69% down from last year.
  • Per Harvard Bioscience's latest filing, its Change in Receivables stood at $210000.0 for Q3 2025, which was up 3548.39% from -$1.8 million recorded in Q2 2025.
  • In the past 5 years, Harvard Bioscience's Change in Receivables registered a high of $3.6 million during Q4 2021, and its lowest value of -$2.8 million during Q2 2024.
  • Over the past 5 years, Harvard Bioscience's median Change in Receivables value was -$584000.0 (recorded in 2021), while the average stood at -$278526.3.
  • In the last 5 years, Harvard Bioscience's Change in Receivables surged by 21052.63% in 2021 and then plummeted by 89731.8% in 2022.
  • Over the past 5 years, Harvard Bioscience's Change in Receivables (Quarter) stood at $3.6 million in 2021, then crashed by 64.12% to $1.3 million in 2022, then decreased by 26.48% to $941000.0 in 2023, then surged by 147.5% to $2.3 million in 2024, then crashed by 90.98% to $210000.0 in 2025.
  • Its last three reported values are $210000.0 in Q3 2025, -$1.8 million for Q2 2025, and -$1.4 million during Q1 2025.